Ofezumir
Registro de marca em vigor (Madri)
Marca Mista depositada no INPI em
12/03/2024 por Incyte Holdings Corporation,
processo nº 501790977, nas classes 05, 16, 44.
Registro em vigor até 12/03/2034.
| Número do processo | 501790977 |
|---|
| Situação | Registro de marca em vigor (Madri) |
|---|
| Apresentação | Mista |
|---|
| Natureza | Madri
Produto/Serviço |
|---|
| Data do depósito | 12/03/2024 |
|---|
| Data da concessão | 09/12/2025 |
|---|
| Vigência até | 12/03/2034 |
|---|
| Titular | Incyte Holdings Corporation |
|---|
| UF · País | — · US |
Classes e especificação
Pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of immunological disorders; pharmaceutical preparations for the treatment of graft versus host disorder (GVHD); pharmaceutical preparations for the treatment of hematological disorders; pharmaceutical preparations for the treatment of hypophosphatemia disorders; pharmaceutical preparations for the treatment of myeloproliferative disorders; pharmaceutical preparations for the treatment of skeletal or chondrocyte disorders; pharmaceutical preparations for the treatment of dermatological disorders.;
Printed brochures, newsletters, and pamphlets in the fields of medical issues, procedures, disease symptoms, patient support and community building.;
Providing medical information to healthcare providers and patients relating to viral, hematological, auto-immune, graft versus host, inflammatory, metabolic and dermatological disorders.;